- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02577835
International Registry for Ambulatory Blood Pressure and Arterial Stiffness Telemonitoring (VASOTENS)
August 2, 2023 updated by: Italian Institute of Telemedicine
This Registry is an investigator-initiated, international, multicenter, observational, prospective study aiming at: i) evaluating non-invasive 24-h ambulatory blood pressure and arterial stiffness estimates (through 24-h pulse wave analysis) in hypertensive subjects; ii) assessing the changes in estimates following treatment; iii) weighing the impact of 24-h pulse wave analysis on target organ damage and cardiovascular prognosis; iv) assessing the relationship between arterial stiffness, blood pressure absolute level and variability, and prognosis.
Approximately 2000 subjects, referred to 20 hypertension clinics for routine diagnostic evaluation and follow-up of hypertension, will be recruited.
Data collection will include ambulatory blood pressure monitoring, performed with a device allowing simultaneous non-invasive assessment of blood pressure and arterial stiffness, and clinical data (including cardiovascular outcomes).
A web-based telemedicine platform will be used for data collection.
Subjects will visit the centers at 6-12 month intervals.
First follow-up results are expected to be available in the next 2-years.
The results of the Registry will help defining the normalcy thresholds for current and future indices derived from 24-h pulse wave velocity, according to outcome data.
They will also provide supporting evidence for the inclusion of such evaluation in recommendations on hypertension management.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The VASOTENS Registry is an international, multicenter, observational, prospective project Actually, it is a large database of ambulatory blood pressure recordings obtained with a non-invasive device, able to determine central blood pressure and various indices of arterial stiffness (mainly pulse wave velocity and augmentation index) over the 24-hours, based on a clinically validated technology of pulse wave analysis of oscillometric blood pressure measurements, integrated in an ambulatory blood pressure monitor.
Specifically, this project aims at creating an international network of centers performing ambulatory blood pressure monitoring and arterial stiffness monitoring, in order to evaluate the impact of such estimates on the clinical outcome of hypertensive patients.
The results of the data collected at baseline and during regular follow-up of hypertensive patients (up to 2 years) will help to provide evidence on the clinical usefulness of such technologies for the screening and follow-up of the hypertensive patients.
The registry will include data from subjects fulfilling the inclusion criteria and whose data are contained in existing databases collected by the participating centers and who are regularly followed-up at the center.
New subjects can be enrolled for this project, but they must be submitted to ambulatory blood pressure monitoring because it is required for evaluating their hypertension status, according to current recommendations.
Data collection is ensured by a dedicated web-based telemedicine platform, including an electronic case report form (e-CRF).
The e-CRF allows collection of patient's clinical data, such as family history, anthropometric data, habits, past and current diseases, therapies, office blood pressure, and laboratory tests, including evaluation of target organ damage.
The project does not involve any type of intervention related to the study and the physicians can manage the patients included in the Registry according to the requirements of clinical practice and current guidelines.
However, as recommended by current guidelines, each patient has to be followed-up with visits occurring at regular intervals (ideally every 6 months, and not less than once a year).
The physicians is also free to use the ambulatory blood pressure data in the clinical management of the patients.
At least 30 Hypertension centers are planned to be involved in the project, each one providing at least 100 patients, which have to be followed-up over time.
Centers will be selected in different countries, initially in Europe, starting from Italy and Russia.
Mandatory criteria of a center to be included in the study are the availability in the facility of a BPLab ambulatory blood pressure monitor, the potential for providing and properly following-up the number of patients required by the protocol, the availability of Internet connection, regular access to the web and human resources to upload ambulatory blood pressure and clinical data.
Study Type
Observational
Enrollment (Actual)
2000
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Buenos Aires, Argentina
- DIM Clínica Privada
-
Buenos Aires, Argentina
- Servicio de Clínica Médica y Sección Hipertensión Arterial, Hospital Italiano de Buenos Aires
-
-
-
-
-
Erevan, Armenia, 00014
- Center of Preventive Cardiology
-
-
-
-
-
Sydney, Australia
- Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University
-
-
-
-
-
Brescia, Italy, 25100
- Dipartimento di Scienze Mediche e Chirurgiche, Università di Brescia, Medicina 2, Spedali Civili
-
Palermo, Italy, 90127
- Unità Operativa di Nefrologia ed Ipertensione, Centro di Riferimento Regionale per l'Ipertensione Arteriosa, Policlinico Paolo Giaccone
-
-
-
-
-
Astana, Kazakhstan
- Department of Functional Diagnostics, Medical Centre Hospital of President's Affairs Administration of The Republic of Kazakhstan
-
-
-
-
-
Guadalajara, Mexico, 44340
- University of Guadalajara, Dept. of Physiology
-
-
-
-
-
Coimbra, Portugal
- Clínica da Aveleira, Instituto de Investigação e Formação Cardiovascular
-
Coimbra, Portugal
- Escola Superior de Tecnologia da Saúde de Coimbra , Instituto Politécnico de Coimbra
-
-
-
-
-
Târgu-Mureş, Romania
- Cardiac Rehabilitation Clinic, Tirgu Mures Emergency Clinical County Hospital
-
-
-
-
-
Chelyabinsk, Russian Federation
- South Ural State Medical University
-
Chita, Russian Federation
- Diagnostics Department, The Hospital within the Russian Railroad Network
-
Moscow, Russian Federation
- Department of Cardiology and Personalized Medicine, Faculty of Doctors' Advanced Training, Peoples' Friendship University of Russia
-
Moscow, Russian Federation
- Department of Cardiology, Sechenov First Moscow State Medical University
-
Moscow, Russian Federation
- Department of Propaedeutics of Internal Diseases, Medical Faculty, Peoples' Friendship University of Russia
-
Moscow, Russian Federation
- Institute of Personalized Medicine, Sechenov First Moscow State Medical University
-
Moscow, Russian Federation
- Lomonosov Moscow State University Clinic, State University
-
Nizhniy Novgorod, Russian Federation
- Volga District Medical Center
-
Petrozavodsk, Russian Federation
- Petrosavodsk Research Center and Department of Faculty Therapy, Infectious Diseases and Epidemiology, Petrozavodsk State University
-
Rostov-at-Don, Russian Federation
- Rostov State Medical University
-
St. Petersburg, Russian Federation
- North-West Federal Medical Research Centre, Department of Epidemiology
-
Volgograd, Russian Federation
- Volgograd State Medical University
-
-
-
-
-
Kyiv, Ukraine
- National Scientific Center "M.D. Strazhesko Institute of Cardiology"
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Suspected hypertensive patients referred to routine diagnostic evaluation for their condition (hypertension) or established hypertensive subjects
Description
Inclusion Criteria:
- Subjects referred to routine diagnostic evaluation for hypertension or established hypertensive subject
- ABPM performed for clinical reasons with a BPLab device
- Valid ambualtory blood pressure recordings (interval between measurements not >30 minutes, at least 70% of expected number of readings, at least 20 valid readings during the day-time and 7 during the night-time)
- Availability of individual measurements for ambulatory blood pressure monitoring
- Availability of basic demographic and clinical information
- Availability of a signed informed consent form
Exclusion Criteria:
- Age <18 years
- Atrial fibrillation, frequent ectopic beats, second or third degree atrioventricular blocks, or other conditions which might make difficult or unreliable the automatic blood pressure measurement with the oscillometric technique
- Upper arm circumference <22 cm
- Pregnancy
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Hypertensive patients
No intervention.
Patients will be sumbitted to standard tests required for hypertension management, including ambulatory blood pressure monitoring, and pharmacologically treated according to recommendations of international guidelines.
The registry will include data from subjects fulfilling the inclusion criteria and whose data are contained in existing databases collected by the participating centers and who are regularly followed-up at the center.
New subjects can be enrolled for this project, but they must be submitted to ambualtory blood pressure monitoring because it is required for evaluating their hypertension status, according to current recommendations.
|
Ambulatory blood pressure monitoring with arterial stiffness evaluation at 6-12 month intervals.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
24-hour Pulse Wave Velocity (PWV)
Time Frame: 2 years
|
24-hour average value for arterial stiffness was assessed through estimation of the time traveled by the pulse wave from the central arterial tree (aorta) to the peripheral arteries (brachial artery) and measured in meters per sec.
The faster the wave travels through the arterial tree, the stiffer the artery is.
|
2 years
|
24-hour Augmentation Index (AI)
Time Frame: 2 years
|
24-hour average value for waves reflection expressed as a percentage.
The augmentation index is a measure of wave reflection and arterial stiffness and is commonly measured as the ratio of the central pulse pressure and the reflected pulse pressure which augments the central blood pressure.
When arteries are stiff, a reflected wave is formed where arteries split.
This reflected wave moves back at the heart and increases the pressure at which the heart has to pump.
The higher the index the stiffer the artery is.
|
2 years
|
24-hour Central Blood Pressure
Time Frame: 2 years
|
24-hour average central aortic pressure expressed in mmHg, as the estimated blood pressure at the level of the thoracic aorta
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
24-hour Systolic Blood Pressure
Time Frame: 2 years
|
Average 24-hour brachial systolic blood pressure (mmHg), namely the systolic blood pressure measured at the level of the brachial artery (upper arm).
|
2 years
|
24-hour Diastolic Blood Pressure
Time Frame: 2 years
|
Average 24-hour brachial diastolic blood pressure (mmHg), namely the diastolic blood pressure measured at the level of the brachial artery (upper arm).
|
2 years
|
Cardiac Damage (Left Ventricular Hypertrophy at Echocardiogram or ECG)
Time Frame: 2 years
|
Left ventricular mass indexed by body surface area (g/m^2) is used to identify left ventricular hypertrophy in case it is increased above a certain threshold (see protocol).
|
2 years
|
Vascular Damage (Carotid Plaque at Ultrasonography)
Time Frame: 2 years
|
Intima media tickness (mm) measured by carotid ultrasonography is used to identify wall thickening or atherosclerotic plaque, when it is above a certain threshold (see protocol).
|
2 years
|
Renal Damage (Urine Protein)
Time Frame: 2 years
|
Urine proteine (mg/24h).
The increase above a certain threshold of urine protein is a sign of renal damage (see protocol).
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Stefano Omboni, MD, Italian Institute of Telemedicine
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Omboni S, Posokhov IN, Parati G, Avolio A, Rogoza AN, Kotovskaya YV, Mule G, Muiesan ML, Orlova IA, Grigoricheva EA, Cardona Munoz E, Zelveian PH, Pereira T, Peixoto Maldonado JM. Vascular Health Assessment of The Hypertensive Patients (VASOTENS) Registry: Study Protocol of an International, Web-Based Telemonitoring Registry for Ambulatory Blood Pressure and Arterial Stiffness. JMIR Res Protoc. 2016 Jun 29;5(2):e137. doi: 10.2196/resprot.5619.
- Omboni S, Posokhov IN, Kotovskaya YV, Protogerou AD, Blacher J. Twenty-Four-Hour Ambulatory Pulse Wave Analysis in Hypertension Management: Current Evidence and Perspectives. Curr Hypertens Rep. 2016 Oct;18(10):72. doi: 10.1007/s11906-016-0681-2.
- Omboni S, Posokhov I, Parati G, Rogoza A, Kotovskaya Y, Arystan A, Avolio A, Barkan V, Bulanova N, Cardona Munoz E, Grigoricheva E, Konradi A, Minyukhina I, Muiesan ML, Mule G, Orlova I, Pereira T, Peixoto Maldonado JM, Statsenko ME, Tilea I, Waisman G; VASOTENS Registry Study Group. Ambulatory blood pressure and arterial stiffness web-based telemonitoring in patients at cardiovascular risk. First results of the VASOTENS (Vascular health ASsessment Of The hypertENSive patients) Registry. J Clin Hypertens (Greenwich). 2019 Aug;21(8):1155-1168. doi: 10.1111/jch.13623. Epub 2019 Jul 11.
- Omboni S, Posokhov I, Parati G, Arystan A, Tan I, Barkan V, Bulanova N, Derevyanchenko M, Grigoricheva E, Minyukhina I, Mule G, Orlova I, Paini A, Peixoto Maldonado JM, Pereira T, Ramos-Becerra CG, Tilea I, Waisman G; VASOTENS Registry Study Group. Variable association of 24-h peripheral and central hemodynamics and stiffness with hypertension-mediated organ damage: the VASOTENS Registry. J Hypertens. 2020 Apr;38(4):701-715. doi: 10.1097/HJH.0000000000002312.
- Omboni S, Campolo L, Panzeri E. Telehealth in chronic disease management and the role of the Internet-of-Medical-Things: the Tholomeus(R) experience. Expert Rev Med Devices. 2020 Jul;17(7):659-670. doi: 10.1080/17434440.2020.1782734. Epub 2020 Jun 30.
- Omboni S, Panzeri E, Campolo L. E-Health in Hypertension Management: an Insight into the Current and Future Role of Blood Pressure Telemonitoring. Curr Hypertens Rep. 2020 Jun 6;22(6):42. doi: 10.1007/s11906-020-01056-y.
- Omboni S, Arystan A, Benczur B. Ambulatory monitoring of central arterial pressure, wave reflections, and arterial stiffness in patients at cardiovascular risk. J Hum Hypertens. 2022 Apr;36(4):352-363. doi: 10.1038/s41371-021-00606-4. Epub 2021 Sep 13.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2015
Primary Completion (Actual)
December 1, 2018
Study Completion (Actual)
April 1, 2022
Study Registration Dates
First Submitted
October 13, 2015
First Submitted That Met QC Criteria
October 14, 2015
First Posted (Estimated)
October 16, 2015
Study Record Updates
Last Update Posted (Actual)
March 1, 2024
Last Update Submitted That Met QC Criteria
August 2, 2023
Last Verified
August 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VASOTENS REGISTRY
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
BayerCompletedPrimary HypertensionChina
-
University of Alabama at BirminghamTroy UniversityCompletedHypertension | Hypertension, Resistant to Conventional Therapy | Uncontrolled Hypertension | Hypertension, White CoatUnited States
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Active, not recruitingWhite Coat Hypertension | Hypertension,EssentialUnited States
-
Universidade Federal de Santa MariaCompletedHealthy Volunteers | Hypertension, EssentialBrazil
-
Addpharma Inc.Completed
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldCompletedIdiopathic Pulmonary Arterial Hypertension | Chronic Thromboembolic Pulmonary HypertensionUnited Kingdom
-
China Academy of Chinese Medical SciencesGuang'anmen Hospital of China Academy of Chinese Medical SciencesCompletedHypertension, Resistant to Conventional Therapy | Primary HypertensionChina
-
Istituto Auxologico ItalianoRecruitingHypertension,Essential | Hypertension, UncontrolledArgentina, China
Clinical Trials on Ambulatory blood pressure monitoring
-
University of MichiganCompletedHypertensionUnited States
-
Italian Institute of TelemedicineItalian Society of Hypertension; Italian Society of General Practitioners; Biotechmed...Recruiting
-
University of AarhusCompleted
-
General Administration of Military Health, TunisiaRecruiting
-
Yokohama City University Medical CenterCompletedDiabetes Mellitus | Renal Failure | Essential Hypertension | Chronic NephropathyJapan
-
University of VigoUniversity of California, Los Angeles; National Institute on Minority Health... and other collaboratorsRecruiting
-
Seoul National University HospitalKangbuk Samsung Hospital; Severance Hospital; Eulji General HospitalUnknownHypertension | Chronic Kidney Diseases | Renal Insufficiency, Chronic | AlbuminuriaKorea, Republic of
-
Arkansas Children's Hospital Research InstitutePediatric Pharmacology Research Units NetworkCompleted
-
Shanghai 10th People's HospitalUnknown
-
University of BurgundyAssociation pour le Développement de la Recherche en Médecine Générale (ADRMG) and other collaboratorsUnknownHypertension | Primary Health Care | Blood Pressure Monitoring, AmbulatoryFrance